313 related articles for article (PubMed ID: 12048741)
1. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
Järventausta K; Leinonen E
Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine induced neuroleptic malignant syndrome--a case review.
Kogoj A; Velikonja I
Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
[TBL] [Abstract][Full Text] [Related]
4. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
Gram LF
Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710
[No Abstract] [Full Text] [Related]
5. Neuroleptic malignant syndrome associated with olanzapine.
Johnson V; Bruxner G
Aust N Z J Psychiatry; 1998 Dec; 32(6):884-6. PubMed ID: 10084355
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome due to olanzapine.
Hall KL; Taylor WH; Ware MR
Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine and NMS.
Hickey C; Stewart C; Lippmann S
Psychiatr Serv; 1999 Jun; 50(6):836-7. PubMed ID: 10375159
[No Abstract] [Full Text] [Related]
8. [Life threatening neuroleptic malignant syndrome due to olanzapine].
Kopf A; Köster J; Schulz A; Krömker H; Becker T
Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.
Berry N; Pradhan S; Sagar R; Gupta SK
Pharmacotherapy; 2003 Feb; 23(2):255-9. PubMed ID: 12587815
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic malignant syndrome associated with olanzapine.
Filice GA; McDougall BC; Ercan-Fang N; Billington CJ
Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
Stanfield SC; Privette T
J Emerg Med; 2000 Nov; 19(4):355-7. PubMed ID: 11074330
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
Reeves RR; Mack JE; Torres RA
Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
Malyuk R; Gibson B; Procyshyn RM; Kang N
Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885
[TBL] [Abstract][Full Text] [Related]
14. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
15. Neuropletic malignant syndrome and olanzapine.
Sierra-Biddle D; Herran A; Diez-Aja S; Gonzalez-Mata JM; Vidal E; Diez-Manrique F; Vazquez-Barquero JL
J Clin Psychopharmacol; 2000 Dec; 20(6):704-5. PubMed ID: 11106147
[No Abstract] [Full Text] [Related]
16. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
Musselman ME; Browning LA; Parker D; Saely S
Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
[TBL] [Abstract][Full Text] [Related]
17. [Neuroleptic malignant syndrome after treatment with olanzapine].
Emborg C
Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.
Mujica R; Weiden P
Am J Psychiatry; 2001 Apr; 158(4):650-1. PubMed ID: 11282706
[No Abstract] [Full Text] [Related]
19. [Neuroleptic malignant syndrome in a patient treated with olanzapine].
Horni G; Meirik K; Lund MB
Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2867-9. PubMed ID: 14600711
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine-associated neuroleptic malignant syndrome.
Kontaxakis VP; Havaki-Kontaxaki BJ; Christodoulou NG; Paplos KG
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):897-902. PubMed ID: 12369263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
